Marie-Claude Trachy-Bourget

1.0k total citations
8 papers, 669 citations indexed

About

Marie-Claude Trachy-Bourget is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Marie-Claude Trachy-Bourget has authored 8 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Marie-Claude Trachy-Bourget's work include Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Click Chemistry and Applications (2 papers). Marie-Claude Trachy-Bourget is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Click Chemistry and Applications (2 papers). Marie-Claude Trachy-Bourget collaborates with scholars based in Canada. Marie-Claude Trachy-Bourget's co-authors include Zuomei Li, Marielle Fournel, Jeffrey M. Besterman, Daniel Delorme, Oscar Moradei, Claire Bonfils, Silvana Leit, Sylvie Fréchette, Ann Kalita and A. Robert MacLeod and has published in prestigious journals such as Journal of Medicinal Chemistry, Environmental Science and Pollution Research and Molecular Cancer Therapeutics.

In The Last Decade

Marie-Claude Trachy-Bourget

8 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie-Claude Trachy-Bourget Canada 8 598 200 157 47 26 8 669
Paul Kwon United States 7 657 1.1× 169 0.8× 78 0.5× 33 0.7× 33 1.3× 9 728
Grace Aldana-Masangkay United States 7 471 0.8× 190 0.9× 47 0.3× 21 0.4× 28 1.1× 9 503
Darcy Kohls United States 6 273 0.5× 82 0.4× 44 0.3× 25 0.5× 18 0.7× 7 339
Nina Reßing Germany 6 279 0.5× 126 0.6× 75 0.5× 15 0.3× 8 0.3× 8 300
Shalu Gupta India 8 264 0.4× 92 0.5× 30 0.2× 19 0.4× 18 0.7× 10 368
Hélène Ste-Croix Canada 4 275 0.5× 110 0.6× 34 0.2× 13 0.3× 14 0.5× 6 319
Markus Kellner Germany 8 512 0.9× 130 0.7× 25 0.2× 11 0.2× 14 0.5× 10 585
C. Gui United States 2 435 0.7× 131 0.7× 17 0.1× 10 0.2× 23 0.9× 2 474
Hana Anderson United States 9 316 0.5× 151 0.8× 67 0.4× 48 1.0× 4 0.2× 17 515
H Chamberlin United States 5 387 0.6× 113 0.6× 23 0.1× 9 0.2× 16 0.6× 7 434

Countries citing papers authored by Marie-Claude Trachy-Bourget

Since Specialization
Citations

This map shows the geographic impact of Marie-Claude Trachy-Bourget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie-Claude Trachy-Bourget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie-Claude Trachy-Bourget more than expected).

Fields of papers citing papers by Marie-Claude Trachy-Bourget

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie-Claude Trachy-Bourget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie-Claude Trachy-Bourget. The network helps show where Marie-Claude Trachy-Bourget may publish in the future.

Co-authorship network of co-authors of Marie-Claude Trachy-Bourget

This figure shows the co-authorship network connecting the top 25 collaborators of Marie-Claude Trachy-Bourget. A scholar is included among the top collaborators of Marie-Claude Trachy-Bourget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie-Claude Trachy-Bourget. Marie-Claude Trachy-Bourget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Debia, Maximilien, et al.. (2016). Characterization of indoor diesel exhaust emissions from the parking garage of a school. Environmental Science and Pollution Research. 24(5). 4655–4665. 11 indexed citations
2.
Fournel, Marielle, Claire Bonfils, Yu Hou, et al.. (2008). MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo. Molecular Cancer Therapeutics. 7(4). 759–768. 271 indexed citations
3.
Moradei, Oscar, Sylvie Fréchette, Isabelle Paquin, et al.. (2007). Novel Aminophenyl Benzamide-Type Histone Deacetylase Inhibitors with Enhanced Potency and Selectivity. Journal of Medicinal Chemistry. 50(23). 5543–5546. 137 indexed citations
4.
Bouchain, Giliane, Silvana Leit, Sylvie Fréchette, et al.. (2003). Development of Potential Antitumor Agents. Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors. Journal of Medicinal Chemistry. 46(5). 820–830. 52 indexed citations
5.
Vaisburg, Arkadii, Naomy Bernstein, Sylvie Fréchette, et al.. (2003). (2-Amino-phenyl)-amides of ω-substituted alkanoic acids as new histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 283–287. 21 indexed citations
6.
Woo, Soon Hyung, Sylvie Fréchette, Giliane Bouchain, et al.. (2002). Structurally Simple Trichostatin A-Like Straight Chain Hydroxamates as Potent Histone Deacetylase Inhibitors. Journal of Medicinal Chemistry. 45(13). 2877–2885. 53 indexed citations
7.
Fournel, Marielle, Marie-Claude Trachy-Bourget, Ann Kalita, et al.. (2002). Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors.. PubMed. 62(15). 4325–30. 72 indexed citations
8.
Bouchain, Giliane, Sylvie Fréchette, Soon Hyung Woo, et al.. (2001). Design and synthesis of a novel class of histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(21). 2847–2850. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026